Founded in 2018 by world-class industry experts, Acclaro Medical is committed to developing, innovating and bringing to market game-changing solutions to address today's unmet medical, aesthetic and surgical practice needs. With a relentless commitment to innovation and a team of dedicated professionals, Acclaro Medical continues to push the boundaries and drive positive change in the aesthetic medical industry. Its proprietary 3DMIRACL™ and Laser Coring™ skin rejuvenation treatments are valued for offering unrivaled aesthetic results complemented by high patient comfort, rapid healing and utmost safety across all skin types.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/29/25 | $23,000,000 | Series B |
3E Bioventures Accelmed Growth Partners  | undisclosed |
